291 related articles for article (PubMed ID: 29345864)
1. Naltrexone and Disulfiram Treatment Response in Veterans With Alcohol Dependence and Co-Occurring Problem-Gambling Features.
Grant JE; Potenza MN; Kraus SW; Petrakis IL
J Clin Psychiatry; 2017; 78(9):e1299-e1306. PubMed ID: 29345864
[TBL] [Abstract][Full Text] [Related]
2. Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders.
Petrakis IL; Poling J; Levinson C; Nich C; Carroll K; Rounsaville B;
Biol Psychiatry; 2005 May; 57(10):1128-37. PubMed ID: 15866552
[TBL] [Abstract][Full Text] [Related]
3. Naltrexone and disulfiram in patients with alcohol dependence and current depression.
Petrakis I; Ralevski E; Nich C; Levinson C; Carroll K; Poling J; Rounsaville B;
J Clin Psychopharmacol; 2007 Apr; 27(2):160-5. PubMed ID: 17414239
[TBL] [Abstract][Full Text] [Related]
4. Naltrexone and disulfiram in patients with alcohol dependence and comorbid post-traumatic stress disorder.
Petrakis IL; Poling J; Levinson C; Nich C; Carroll K; Ralevski E; Rounsaville B
Biol Psychiatry; 2006 Oct; 60(7):777-83. PubMed ID: 17008146
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetics of naltrexone and disulfiram in alcohol dependent, dually diagnosed veterans.
Arias AJ; Gelernter J; Gueorguieva R; Ralevski E; Petrakis IL
Am J Addict; 2014; 23(3):288-93. PubMed ID: 24724887
[TBL] [Abstract][Full Text] [Related]
6. Quality of life in veterans with alcohol dependence and co-occurring mental illness.
Ralevski E; Gianoli MO; McCarthy E; Petrakis I
Addict Behav; 2014 Feb; 39(2):386-91. PubMed ID: 23890764
[TBL] [Abstract][Full Text] [Related]
7. A double blind, placebo-controlled trial that combines disulfiram and naltrexone for treating co-occurring cocaine and alcohol dependence.
Pettinati HM; Kampman KM; Lynch KG; Xie H; Dackis C; Rabinowitz AR; O'Brien CP
Addict Behav; 2008 May; 33(5):651-67. PubMed ID: 18079068
[TBL] [Abstract][Full Text] [Related]
8. Psychotic spectrum disorders and alcohol abuse: a review of pharmacotherapeutic strategies and a report on the effectiveness of naltrexone and disulfiram.
Petrakis IL; Nich C; Ralevski E
Schizophr Bull; 2006 Oct; 32(4):644-54. PubMed ID: 16887890
[TBL] [Abstract][Full Text] [Related]
9. The impact of personality disorders on alcohol-use outcomes in a pharmacotherapy trial for alcohol dependence and comorbid Axis I disorders.
Ralevski E; Ball S; Nich C; Limoncelli D; Petrakis I
Am J Addict; 2007; 16(6):443-9. PubMed ID: 18058408
[TBL] [Abstract][Full Text] [Related]
10. Adherence Across FDA-Approved Medications for Alcohol Use Disorder in a Veterans Administration Population.
Walker JR; Korte JE; McRae-Clark AL; Hartwell KJ
J Stud Alcohol Drugs; 2019 Sep; 80(5):572-577. PubMed ID: 31603760
[TBL] [Abstract][Full Text] [Related]
11. Comparison of healthcare utilization among patients treated with alcoholism medications.
Mark TL; Montejano LB; Kranzler HR; Chalk M; Gastfriend DR
Am J Manag Care; 2010; 16(12):879-88. PubMed ID: 21348558
[TBL] [Abstract][Full Text] [Related]
12. Disulfiram, an option for the treatment of pathological gambling?
Mutschler J; Bühler M; Grosshans M; Diehl A; Mann K; Kiefer F
Alcohol Alcohol; 2010; 45(2):214-6. PubMed ID: 20083479
[TBL] [Abstract][Full Text] [Related]
13. Alcohol dependence treatments: comprehensive healthcare costs, utilization outcomes, and pharmacotherapy persistence.
Baser O; Chalk M; Rawson R; Gastfriend DR
Am J Manag Care; 2011 Jun; 17 Suppl 8():S222-34. PubMed ID: 21761948
[TBL] [Abstract][Full Text] [Related]
14. A one-year pragmatic trial of naltrexone vs disulfiram in the treatment of alcohol dependence.
De Sousa A; De Sousa A
Alcohol Alcohol; 2004; 39(6):528-31. PubMed ID: 15525790
[TBL] [Abstract][Full Text] [Related]
15. [Meta-analysis of pharmacological therapy with acamprosate, naltrexone, and disulfiram--a systematic review].
Petrov I; Krogh J; Nordentoft M
Ugeskr Laeger; 2011 Nov; 173(48):3103-9. PubMed ID: 22118653
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of disulfiram for the treatment of alcohol dependence assessed with a multicenter randomized controlled trial.
Yoshimura A; Kimura M; Nakayama H; Matsui T; Okudaira F; Akazawa S; Ohkawara M; Cho T; Kono Y; Hashimoto K; Kumagai M; Sahashi Y; Roh S; Higuchi S
Alcohol Clin Exp Res; 2014 Feb; 38(2):572-8. PubMed ID: 24117666
[TBL] [Abstract][Full Text] [Related]
17. Coadministration of disulfiram and lorazepam in the treatment of alcohol dependence and co-occurring anxiety disorder: an open-label pilot study.
Bogenschutz MP; Bhatt S; Bohan J; Foster B; Romo P; Wilcox CE; Tonigan JS
Am J Drug Alcohol Abuse; 2016 Sep; 42(5):490-499. PubMed ID: 27184605
[TBL] [Abstract][Full Text] [Related]
18. Naltrexone in alcohol dependence.
Brewer C
Lancet; 1995 Nov; 346(8986):1374. PubMed ID: 7475809
[No Abstract] [Full Text] [Related]
19. The state of pharmacotherapy for the treatment of alcohol dependence.
Garbutt JC
J Subst Abuse Treat; 2009 Jan; 36(1):S15-23; quiz S24-5. PubMed ID: 19062347
[TBL] [Abstract][Full Text] [Related]
20. A randomized, multicentre, open-label, comparative trial of disulfiram, naltrexone and acamprosate in the treatment of alcohol dependence.
Laaksonen E; Koski-Jännes A; Salaspuro M; Ahtinen H; Alho H
Alcohol Alcohol; 2008; 43(1):53-61. PubMed ID: 17965444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
